X
IDYA icon

Xponance’s IDEAYA Biosciences IDYA Stock Holding History

Xponance’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
11,435
+3,569
+45% +$109K ﹤0.01% 1184
2026
Q1 		$262K Buy
7,866
+1,551
+25% +$52K ﹤0.01% 1351
2025
Q4 		$218K Buy
+6,315
New +$201K ﹤0.01% 1347

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Xponance's IDYA Position: Q2 2026 in Review

Xponance increased its IDEAYA Biosciences (IDYA) stake by 45% in Q2 2026, buying an estimated $109K and bringing the position to 11,435 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Xponance first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Xponance held 11,435 shares of IDEAYA Biosciences worth $426K as of Q2 2026.
  • Xponance bought 3,569 IDEAYA Biosciences shares in Q2 2026, an estimated $109K.
  • IDEAYA Biosciences made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1184 holding.
  • Xponance first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.